Novartis Joins MRGPRX2 Race Through $800m+ Kyorin Deal

Addition To CSU Portfolio

 
• By Lisa Takagi
  
Kyorin Novartis deal
$800m deal with Kyorin has brought another CSU candidate to Novartis. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Therapy Areas